Results from landmark M D Anderson CAR-NK clin... - CLL Support
Results from landmark M D Anderson CAR-NK clinical trial for B cell (CD19+) blood cancers
You need to be a member of this community to see this post.
Read more about...
23 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
Axi-Cel (anti-CD19 CAR T-cell therapy FMC63-28Z) Induces Durable Remissions in Relapsed CLL, B-Cell Lymphoma
Patients with relapsed chronic lymphocytic leukemia (CLL) and B-cell lymphoma who received the...
Interpretation of blood test
I found CLL club is very helpful and people are very cooperative so I decided to put my query...
An Early Look at When CAR-T Therapy Fails Patients With CLL
Not exactly an optimistic report.
Dr James Gerson, MD, - "Not a lot is known as to what happens in...
Scientists hail autoimmune disease therapy breakthrough - implications for CLL patients?
Yesterday it was reported that five young patients, who had suffered with systemic lupus...
T-cell /Cellular Immune Responses in Patients with CLL from the Pfizer-BioNTech COVID-19 Vaccine (BNT162b mRNA Covid19 Vaccine)
From Dr Tamar Tadmor, Head of the Israeli CLL study group at iwCLL.
Patients with CLL suffer from...
Related Posts
Pirtobrutinib triple trial Cycle 7 update
flow cytometry is showing about 74% CLL involvement. 
Why we need to track the absolute lymphocyte count (ALC), not white blood cell count (WBC) to monitor CLL
Richter's Syndrome! One pill, Triple Combination Therapy is in clinical trial for Richter’s Transformation & De Novo Large B-Cell Lymphoma- Measurable residual disease (MRD) status predicts Progression Free Survival (PFS) for patients with Chronic Lymphocytic Leukemia (CLL)
